Skip to content

Clinical trials

Phase 2 Lymphoma, Non-Hodgkin trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 2 Country / region: Belgium Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20083
20091
20102
20122
20132
20141
20172
20182
20195
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated7
Active, not recruiting3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Incyte Corporation3
Seagen Inc.2
University of Liege2
miRagen Therapeutics, Inc.2
Actuate Therapeutics Inc.1
Bayer1
Bristol-Myers Squibb1
Cephalon1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin26
Lymphoma8
Lymphoma, Large B-Cell, Diffuse7
Neoplasms5
Hodgkin Disease4
Lymphoma, Mantle-Cell4
Myeloproliferative Disorders4
Immunoproliferative Disorders3
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphatic Diseases3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.